Bin Chen Selected Research

Port-Wine Stain (Nevus Flammeus)

4/2022	Vascular damage mechanism and parameter optimization under alexandrite laser irradiation: a theoretical study.
1/2022	Theoretical and in vivo investigations of morphology and concentration of gold nanoparticles for laser surgery.
10/2020	Retrospective study of the treatment of port-wine stains with 595-nm pulsed dye laser in 261 Chinese patients.
9/2020	Thermal coagulum formation and hemostasis during repeated multipulse Nd:YAG laser treatment of cutaneous vascular lesions: animal experiment study.
12/2018	Correction to: Glucose in Conjunction with Multiple Laser Pulses on Laser Treatment of Port-wine Stain: An in vivo Study.
1/2018	Gold nanospheres enhanced photothermal therapy in a rat model.
1/2018	Glucose in Conjunction with Multiple Laser Pulses on Laser Treatment of Port-wine Stain: An in vivo Study.
11/2017	Nd:YAG laser combined with gold nanorods for potential application in port-wine stains: an in vivo study.
8/2017	Multiple laser pulses in conjunction with an optical clearing agent to improve the curative effect of cutaneous vascular lesions.
4/2017	Dynamic optical absorption characteristics of blood after slow and fast heating.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bin Chen Research Topics

Disease

250	Neoplasms (Cancer) 11/2022 - 01/2002
41	Inflammation (Inflammations) 04/2022 - 05/2005
38	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2005
38	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2002
35	Infections 11/2022 - 05/2007
35	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2008
26	Wounds and Injuries (Trauma) 06/2022 - 03/2007
21	Carcinogenesis 01/2022 - 03/2005
20	Hypoxia (Hypoxemia) 02/2022 - 03/2007
20	Pain (Aches) 09/2021 - 07/2003
18	Malaria 10/2022 - 03/2012
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 01/2013
17	Carcinoma (Carcinomatosis) 01/2022 - 07/2006
16	Stroke (Strokes) 07/2022 - 03/2009
16	Stomach Neoplasms (Stomach Cancer) 04/2022 - 03/2006
15	Lung Neoplasms (Lung Cancer) 11/2022 - 08/2013
15	Fibrosis (Cirrhosis) 05/2022 - 04/2008
15	Ischemia 01/2022 - 12/2009
13	Port-Wine Stain (Nevus Flammeus) 04/2022 - 01/2015
13	Osteoporosis 01/2021 - 11/2003
13	Osteosarcoma (Osteogenic Sarcoma) 08/2020 - 01/2015
12	Ischemic Stroke 03/2022 - 11/2015
12	Infarction (Infarctions) 03/2022 - 02/2006
12	Obesity 01/2022 - 12/2012
12	Aortic Dissection 01/2022 - 10/2005
12	Hemorrhage 09/2021 - 08/2013
11	Brain Ischemia (Cerebral Ischemia) 07/2022 - 02/2008
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2009
11	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2011
11	Thrombosis (Thrombus) 09/2021 - 08/2008
11	Lymphatic Metastasis 01/2021 - 03/2005
10	Cognitive Dysfunction 07/2022 - 12/2011
10	Liver Neoplasms (Liver Cancer) 01/2022 - 04/2005
9	Vasculitis (Vasculitides) 01/2022 - 11/2006
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2010
9	Glioma (Gliomas) 01/2022 - 04/2014
9	Hypertension (High Blood Pressure) 11/2021 - 07/2009
9	Insulin Resistance 04/2021 - 12/2012
9	Cerebral Hemorrhage 01/2021 - 10/2016
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 11/2018
9	Aneurysm (Aneurysms) 10/2018 - 05/2006
8	Reperfusion Injury 05/2022 - 08/2005
8	COVID-19 05/2022 - 01/2020
8	Chronic Limb-Threatening Ischemia 05/2022 - 08/2013
8	Hematoma 04/2022 - 08/2013
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 12/2008
8	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 03/2018
8	Rheumatoid Arthritis 10/2021 - 01/2014
8	Atherosclerosis 08/2021 - 11/2009
8	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2011

Drug/Important Bio-Agent (IBA)

69	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2003
48	Pharmaceutical PreparationsIBA 07/2022 - 11/2002
40	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
31	Messenger RNA (mRNA)IBA 04/2022 - 11/2003
30	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2013
27	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2002
26	Biological ProductsIBA 03/2022 - 03/2006
25	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2006
21	RNA (Ribonucleic Acid)IBA 02/2022 - 03/2014
19	Therapeutic UsesIBA 07/2022 - 03/2005
19	CytokinesIBA 10/2021 - 05/2005
16	Long Noncoding RNAIBA 01/2022 - 01/2016
16	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 04/2003
15	EnzymesIBA 07/2022 - 04/2005
13	CollagenIBA 01/2022 - 09/2009
13	Verteporfin (Visudyne)FDA Link 01/2020 - 03/2003
11	IronIBA 01/2021 - 09/2011
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2005
10	LigandsIBA 04/2022 - 01/2009
10	protoporphyrin IXIBA 01/2022 - 09/2006
10	Small Interfering RNA (siRNA)IBA 01/2022 - 09/2008
10	Estrogens (Estrogen)FDA Link 11/2020 - 01/2002
9	Oxygen (Dioxygen)IBA 01/2022 - 03/2003
9	LipidsIBA 01/2022 - 03/2003
9	C-Reactive ProteinIBA 11/2021 - 03/2011
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021 - 12/2007
9	Indicators and Reagents (Reagents)IBA 11/2020 - 01/2011
9	Peptides (Polypeptides)IBA 02/2020 - 03/2009
9	Photosensitizing Agents (Photosensitizers)IBA 01/2020 - 10/2003
8	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 11/2008
8	salicylhydroxamic acid (SHAM)IBA 05/2022 - 01/2013
8	CalciumIBA 05/2022 - 01/2012
8	Aminolevulinic Acid (Levulan)FDA Link 01/2022 - 09/2006
8	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 05/2008
8	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 04/2013
8	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 04/2011
8	LipopolysaccharidesIBA 01/2021 - 04/2015

Therapy/Procedure

112	Therapeutics 06/2022 - 01/2005
31	Drug Therapy (Chemotherapy) 11/2022 - 12/2005
28	Stents 11/2022 - 10/2005
24	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2002
23	Lasers (Laser) 04/2022 - 03/2002
20	Endovascular Aneurysm Repair 01/2022 - 11/2008
17	Immunotherapy 11/2022 - 08/2013
13	Length of Stay 01/2022 - 10/2005
12	Radiotherapy 08/2021 - 05/2005
11	Electroacupuncture 07/2022 - 03/2014
10	Transplantation 01/2022 - 08/2009
9	Aftercare (After-Treatment) 01/2021 - 03/2002
8	Ligation 01/2021 - 02/2006